{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T21:53:21Z","timestamp":1788126801589,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.imlet.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T20:59:13Z","timestamp":1592945953000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The ambiguity of opioids revealed by immunology is changing the knowledge and the therapeutic approach in cancer and non-cancer pain: A narrative review"],"prefix":"10.1016","volume":"226","author":[{"given":"Angela","family":"Santoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Arcuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2020.06.011_bib0005","series-title":"World Health Organization Cancer Pain Relief","year":"1986"},{"key":"10.1016\/j.imlet.2020.06.011_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-3959(93)90007-C","article-title":"Is disease progression the major factor in morphine \u2018\u201ctolerance\u201d\u2019 in cancer pain treatment?","volume":"55","author":"Collin","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0885-3924(02)00425-6","article-title":"Preliminary in vivo experimental evidence on intratumoral morphine uptake. Possible clinical implications in cancer pain and opioid responsiveness","volume":"24","author":"Arcuri","year":"2002","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.imlet.2020.06.011_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jnci\/78.1.141","article-title":"Modulation of murine neuroblastoma in nude mice by opioid antagonists","volume":"78","author":"Zagon","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.imlet.2020.06.011_bib0025","first-page":"1053","article-title":"Opioid growth factor regulates the cell cycle of human neoplasias","volume":"17","author":"Zagon","year":"2000","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0030","first-page":"78","article-title":"Can tumors act as opioid traps, mimicking opioid tolerance?","volume":"16","author":"Arcuri","year":"1998","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.imlet.2020.06.011_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(00)00490-5","article-title":"The role of neuroinflammation and neuroimmune activation in persistent pain","volume":"90","author":"DeLeo","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0040","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1073\/pnas.90.11.5162","article-title":"Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor","volume":"90","author":"Kolesnikov","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2020.06.011_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3835(99)00227-X","article-title":"Mu3 opiate receptor expression in lung and lung carcinoma: ligand binding and coupling to nitric oxide release","volume":"146","author":"Fimiani","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imlet.2020.06.011_bib0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2020.06.011_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0060","first-page":"40","article-title":"Breakthrough pain: a single mask for varying painful situations: therapeutic reflexes in cancer pain","volume":"1","author":"Arcuri","year":"2012","journal-title":"Transl. Med. Special Issue"},{"key":"10.1016\/j.imlet.2020.06.011_bib0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0305-7372(98)90005-6","article-title":"Breakthrough pain in cancer patients: pathophysiology and treatment","volume":"24","author":"Mercadante","year":"1998","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.imlet.2020.06.011_bib0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(94)90084-1","article-title":"Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists","volume":"59","author":"Sj\u00f8gren","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0885-3924(03)00258-6","article-title":"Hyperalgesia: an emerging iatrogenic syndrome","volume":"26","author":"Mercadante","year":"2003","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.imlet.2020.06.011_bib0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pain.2008.04.025","article-title":"The Kyoto protocol of IASP basic pain terminology","volume":"137","author":"Loeser","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-5728(97)00222-1","article-title":"The opioid\u2013cytokine connection","volume":"83","author":"Peterson","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevImmunol.v16.i2.10","article-title":"Opioid and opiate immunoregulatory processes","volume":"16","author":"Stefano","year":"1996","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-5728(03)00213-3","article-title":"Different mechanisms of intrinsic pain inhibition in early and late inflammation","volume":"141","author":"Machelska","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm908","article-title":"Attacking pain at its source: new perspectives on opioids","volume":"9","author":"Stein","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0105","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/3942","article-title":"Can inflammation relieve pain?","volume":"4","author":"Porreca","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0110","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/4017","article-title":"Pain control in inflammation governed by selectins","volume":"4","author":"Machelska","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0304-3959(02)00019-2","article-title":"No pain, no gain: clinical excellence and scientific rigour--lessons learned from IA morphine","volume":"98","author":"Kalso","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0304-3959(99)00156-6","article-title":"Intraarticular morphine versus dexamethasone in chronic arthritis","volume":"83","author":"Stein","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd1852","article-title":"Chemokines: integrators of pain and inflammation","volume":"4","author":"White","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.imlet.2020.06.011_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrn3858","article-title":"Opioid and chemokine receptor crosstalk: a promising target for pain therapy?","volume":"16","author":"M\u00e9lik Parsadaniantz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(01)00437-7","article-title":"A rat model of bone cancer pain","volume":"96","author":"Medhurst","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","article-title":"Molecular mechanisms of cancer pain","volume":"2","author":"Mantyh","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imlet.2020.06.011_bib0145","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ijc.10999","article-title":"Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system","volume":"104","author":"Sabino","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.imlet.2020.06.011_bib0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0304-3959(02)00102-1","article-title":"Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain","volume":"99","author":"Luger","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-6576.1997.tb04624.x","article-title":"NMDA receptor antagonists: interactions with opioids","volume":"41","author":"Dickenson","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.imlet.2020.06.011_bib0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3959(01)00359-1","article-title":"Spinal cord glia: new players in pain","volume":"93","author":"Watkins","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbi.2004.08.004","article-title":"Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences","volume":"19","author":"Wieseler-Frank","year":"2005","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imlet.2020.06.011_bib0170","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0175","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","article-title":"Do we need a third mechanistic descriptor for chronic pain states?","volume":"157","author":"Kosek","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP Classification of chronic pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/j.pain.0000000000001390","article-title":"Treede RD; IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic primary pain","volume":"160","author":"Nicholas","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrn.2016.162","article-title":"Structural plasticity and reorganisation in chronic pain","volume":"18","author":"Kuner","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ejp.1140","article-title":"Assessment and manifestation of central sensitisation across different chronic pain conditions","volume":"22","author":"Arendt-Nielsen","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0200","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1097\/PR9.0000000000000570","article-title":"The dark side of opioids in pain management: basic science explains clinical observation","author":"Rivat","year":"2016","journal-title":"Pain Rep."},{"key":"10.1016\/j.imlet.2020.06.011_bib0205","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1097\/j.pain.0000000000001680","article-title":"Refractory dependence on opioid analgesics","volume":"160","author":"Ballantyne","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0210","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1097\/j.pain.0000000000001688","article-title":"Withdrawal from an opioid induces a transferable memory trace in the cerebrospinal fluid","volume":"160","author":"Drdla-Schutting","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0215","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/j.pain.0000000000001061","article-title":"High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls","volume":"158","author":"B\u00e4ckryd","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12094-016-1529-6","article-title":"Chronic opioid therapy in long-term cancer survivors","volume":"19","author":"Carmona-Bayonas","year":"2017","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0225","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0028-3908(94)90051-5","article-title":"The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat","volume":"33","author":"Meller","year":"1994","journal-title":"Neuropharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.imlet.2020.06.011_bib0230","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: is chronic pain a gliopathy?","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/eujp.2000.0177","article-title":"Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat","volume":"4","author":"Reeve","year":"2000","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0240","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0962-8924(01)02004-9","article-title":"Toll receptors in innate immunity","volume":"11","author":"Imler","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0245","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.imlet.2020.06.011_bib0250","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0501634102","article-title":"The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy","volume":"102","author":"Tanga","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2020.06.011_bib0255","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpain.2014.04.001","article-title":"Dougherty PM Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy","volume":"15","author":"Li","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0260","doi-asserted-by":"crossref","first-page":"15450","DOI":"10.1523\/JNEUROSCI.3859-11.2011","article-title":"Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice","volume":"31","author":"Sorge","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0265","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0306-4522(00)00057-9","article-title":"Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures","volume":"97","author":"Liu","year":"2000","journal-title":"Neuroscience"},{"issue":"8613","key":"10.1016\/j.imlet.2020.06.011_bib0270","first-page":"2699","article-title":"Effects of prolonged naloxone infusion in septic shock","volume":"2","author":"Roberts","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2020.06.011_bib0275","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2020.06.011_bib0280","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","article-title":"The \u201ctoll\u201d of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia","volume":"30","author":"Watkins","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0285","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tins.2016.10.003","article-title":"Nitroxidative signaling mechanisms in pathological pain","volume":"39","author":"Grace","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0290","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1084\/jem.20180800","article-title":"TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG","volume":"215","author":"Zhang","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2017.10.006","article-title":"Toll-like receptors and their role in persistent pain","volume":"184","author":"Lacagnina","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.imlet.2020.06.011_bib0300","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1073\/pnas.1602070113","article-title":"Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation","volume":"113","author":"Grace","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2020.06.011_bib0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jnnp-2018-318556","article-title":"Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies","volume":"91","author":"Xu","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.imlet.2020.06.011_bib0310","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jpain.2010.08.003","article-title":"Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice","volume":"12","author":"Kim","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0315","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3852","article-title":"The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase","volume":"21","author":"Vicu\u00f1a","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0320","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0325","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fnins.2020.00142","article-title":"Cytotoxic immunity in peripheral nerve injury and pain","volume":"14","author":"Davies","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0330","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.cell.2018.12.022","article-title":"Natural killer cells degenerate intact sensory afferents following nerve injury","volume":"176","author":"Davies","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2020.06.011_bib0335","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1523\/JNEUROSCI.3708-15.2016","article-title":"CD8+ T cells and endogenous IL-10 are required for resolution of chemotherapy-induced neuropathic pain","volume":"36","author":"Krukowski","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0340","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/j.pain.0000000000001512","article-title":"Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice","volume":"160","author":"Laumet","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0345","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pain.2006.06.009","article-title":"Critical issues on opioids in chronic non-cancer pain: an epidemiological study","volume":"125","author":"Eriksen","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0350","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","article-title":"Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study","volume":"121","author":"Sacerdote","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0355","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/cncr.20028","article-title":"Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids","volume":"100","author":"Rajagopal","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.imlet.2020.06.011_bib0360","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jama.283.13.1710","article-title":"Trends in medical use and abuse of opioid analgesics","volume":"283","author":"Joranson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.imlet.2020.06.011_bib0365","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3959(02)00422-0","article-title":"Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy","volume":"100","author":"Mao","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0370","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000087658","article-title":"Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?","volume":"14","author":"King","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.imlet.2020.06.011_bib0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00391-2","article-title":"Hyperalgesic responses in methadone maintenance patients","volume":"90","author":"Doverty","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0380","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1090-3801(02)00143-X","article-title":"Recommendations for using opioids in chronic non-cancer pain","volume":"7","author":"Kalso","year":"2003","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0385","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0390","first-page":"3","article-title":"Opioid misuse: can it only happen in America?","volume":"82","author":"Porter","year":"2016","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0395","doi-asserted-by":"crossref","first-page":"6","DOI":"10.23736\/S0375-9393.16.11617-7","article-title":"Opioids and chronic pain. Data from the \"other side of the pond\"","volume":"83","author":"Allegri","year":"2017","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0400","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMp1714529","article-title":"The public and the opioid-abuse epidemic","volume":"378","author":"Blendon","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0405","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00000542-200002000-00009","article-title":"Preemptive hyperalgesia, not analgesia?","volume":"92","author":"Eisenach","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.imlet.2020.06.011_bib0410","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000542-200002000-00029","article-title":"Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine","volume":"92","author":"C\u00e9l\u00e8rier","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.imlet.2020.06.011_bib0415","doi-asserted-by":"crossref","first-page":"65","DOI":"10.36076\/ppj.2013\/16\/65","article-title":"A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: is hydromorphone therapy a double-edged sword?","volume":"16","author":"Suzan","year":"2013","journal-title":"Pain Phys."},{"key":"10.1016\/j.imlet.2020.06.011_bib0420","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1097\/j.pain.0000000000001652","article-title":"Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats","volume":"160","author":"Green-Fulgham","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0425","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.pain.2014.07.011","article-title":"Peripheral opioid receptor blockade increases postoperative morphine demands--a randomized, double-blind, placebo-controlled trial","volume":"155","author":"Jagla","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0430","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejphar.2018.06.008","article-title":"Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice","volume":"833","author":"Shinohara","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0435","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/acschemneuro.7b00195","article-title":"Novel opioid analgesics and side effects","volume":"8","author":"Del Vecchio","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0440","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.imlet.2020.06.011_bib0445","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/pr.110.004135","article-title":"Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia","volume":"63","author":"Hutchinson","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.imlet.2020.06.011_bib0450","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/bph.13394","article-title":"Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4","volume":"173","author":"Wang","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0455","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tips.2014.07.002","article-title":"Translational potential of naloxone and naltrexone as TLR4 antagonists","volume":"35","author":"Watkins","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0460","first-page":"200","article-title":"Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling","volume":"16","author":"Due","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imlet.2020.06.011_bib0465","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpain.2012.10.005","article-title":"Epigenetic regulation of opioid induced hyperalgesia, dependence, and tolerance in mice","volume":"14","author":"Liang","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0470","first-page":"12","article-title":"Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure","author":"Sahbaie","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0475","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor sensory neuron-immune interactions in pain and inflammation","volume":"38","author":"Pinho-Ribeiro","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0480","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12974-016-0735-z","article-title":"Machelska H Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides","volume":"13","author":"Pannell","year":"2016","journal-title":"Neuroinflammation"},{"key":"10.1016\/j.imlet.2020.06.011_bib0485","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnmol.2019.00216","article-title":"T cells as an emerging target for chronic pain therapy","volume":"12","author":"Laumet","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0490","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/j.pain.0000000000001702","article-title":"Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patients","volume":"161","author":"Zhou","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0495","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archinternmed.2011.2156","article-title":"What are we treating with long-term opioid therapy?","volume":"172","author":"Sullivan","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.imlet.2020.06.011_bib0500","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41571-018-0143-7","article-title":"Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer","volume":"16","author":"Arthur","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.06.002","article-title":"Pain therapy - Are there new options on the horizon?","volume":"33","author":"Stein","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.04.007","article-title":"New concepts of pain","volume":"33","author":"Trouvin","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0515","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biopsych.2019.06.017","article-title":"Capturing novel non-opioid pain targets","volume":"87","author":"Woolf","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.imlet.2020.06.011_bib0520","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/j.pain.0000000000000464","article-title":"What can evolutionary theory tell us about chronic pain?","volume":"157","author":"Williams","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbi.2006.09.004","article-title":"Conceptual development of the immune system as a sixth sense","volume":"21","author":"Blalock","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imlet.2020.06.011_bib0530","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/j.pain.0000000000001060","article-title":"Hijacking the endogenous opioid system to treat pain: who thought it would be so complicated?","volume":"158","author":"Clauw","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0535","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1097\/PR9.0000000000000599","article-title":"The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents","volume":"2","author":"H\u00e4user","year":"2017","journal-title":"Pain Rep."},{"key":"10.1016\/j.imlet.2020.06.011_bib0540","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3389\/fimmu.2019.02914","article-title":"Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies","volume":"10","author":"Franchi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0545","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.tips.2018.08.001","article-title":"Immunopharmacotherapies for treating opioid use disorder","volume":"39","author":"Banks","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.imlet.2020.06.011_bib0550","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2015.12.011","article-title":"Opioid switching in cancer pain: from the beginning to nowadays","volume":"99","author":"Mercadante","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.imlet.2020.06.011_bib0555","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40263-019-00660-0","article-title":"Opioid-induced tolerance and hyperalgesia","volume":"33","author":"Mercadante","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.imlet.2020.06.011_bib0560","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pain.2005.07.021","article-title":"Opioids: from analgesia to anti-hyperalgesia?","volume":"118","author":"Simonnet","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.06.011_bib0565","unstructured":"Scuola Medica Salernitana. Flos Medicinae Scholae Salerni."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:37:22Z","timestamp":1759045042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247820303369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":113,"alternative-id":["S0165247820303369"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2020.06.011","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ambiguity of opioids revealed by immunology is changing the knowledge and the therapeutic approach in cancer and non-cancer pain: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}